Rockwell CE et al. |
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. |
2006 |
Mol. Pharmacol. |
pmid:16611855
|
Szabo B et al. |
Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. |
2006 |
J. Physiol. (Lond.) |
pmid:16973696
|
Kasai HF et al. |
Studies on high-energy collision-induced dissociation of endogenous cannabinoids: 2-arachidonoylglycerol and n-arachidonoylethanolamide in FAB-mass spectrometry. |
2006 |
Anal Sci |
pmid:16837740
|
Mechoulam R et al. |
Endocannabinoids, feeding and suckling--from our perspective. |
2006 |
Int J Obes (Lond) |
pmid:16570101
|
Matias I et al. |
Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. |
2006 |
Int J Obes (Lond) |
pmid:16570107
|
Waku K |
[Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol]. |
2006 |
Yakugaku Zasshi |
pmid:16462096
|
Guagnini F et al. |
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P. |
2006 |
Gut |
pmid:16423891
|
Bari M et al. |
New insights into endocannabinoid degradation and its therapeutic potential. |
2006 |
Mini Rev Med Chem |
pmid:16515464
|
Bari M et al. |
Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells. |
2006 |
J. Immunol. |
pmid:17015679
|
Spoto B et al. |
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol. |
2006 |
Biochimie |
pmid:16949718
|
Gough NR |
Focus issue: signaling lipids. |
2006 |
Sci. STKE |
pmid:16467192
|
Wagner JA et al. |
2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. |
2006 |
J. Cardiovasc. Pharmacol. |
pmid:16775503
|
van der Stelt M et al. |
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. |
2006 |
Cell. Mol. Life Sci. |
pmid:16732431
|
Parkkari T et al. |
Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE). |
2006 |
Bioorg. Med. Chem. |
pmid:16403642
|
D'Argenio G et al. |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. |
2006 |
FASEB J. |
pmid:16403786
|
Suplita RL et al. |
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. |
2006 |
Neuropharmacology |
pmid:16316669
|
Juan-Picó P et al. |
Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. |
2006 |
Cell Calcium |
pmid:16321437
|
Blüher M et al. |
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. |
2006 |
Diabetes |
pmid:17065342
|
Oka S et al. |
Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. |
2006 |
J. Immunol. |
pmid:17142782
|
Oka S et al. |
Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol. |
2006 |
Eur. J. Pharmacol. |
pmid:16647054
|
Melis M et al. |
Protective activation of the endocannabinoid system during ischemia in dopamine neurons. |
2006 |
Neurobiol. Dis. |
pmid:16762556
|
Malcher-Lopes R et al. |
Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. |
2006 |
J. Neurosci. |
pmid:16775153
|
Kishimoto S et al. |
Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants. |
2006 |
Int. Arch. Allergy Immunol. |
pmid:16772720
|
Hermann A et al. |
2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook. |
2006 |
AAPS J |
pmid:16808043
|
Yoshida T et al. |
Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. |
2006 |
J. Neurosci. |
pmid:16672646
|
Kurabayashi M et al. |
2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver. |
2005 Jan-Feb |
J Invest Surg |
pmid:15804949
|
van der Stelt M et al. |
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. |
2005 |
FASEB J. |
pmid:15894565
|
Lambert DM and Fowler CJ |
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. |
2005 |
J. Med. Chem. |
pmid:16078824
|
Hayase T et al. |
Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands. |
2005 |
Behav Pharmacol |
pmid:16148444
|
Venderova K et al. |
Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. |
2005 |
Exp. Neurol. |
pmid:15899265
|
Gokoh M et al. |
2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells. |
2005 |
Biochem. J. |
pmid:15456404
|
Hohmann AG et al. |
An endocannabinoid mechanism for stress-induced analgesia. |
2005 |
Nature |
pmid:15973410
|
Sancho R et al. |
Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine. |
2005 |
J. Immunol. |
pmid:16148147
|
Harada N et al. |
Effects of cannabinoids on colonic muscle contractility and tension in guinea pigs. |
2005 |
J Nippon Med Sch |
pmid:15834207
|
Oka S et al. |
Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear. |
2005 |
J. Biol. Chem. |
pmid:15749716
|
Kishimoto S et al. |
Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells. |
2005 |
J. Biochem. |
pmid:15749836
|
Julien B et al. |
Antifibrogenic role of the cannabinoid receptor CB2 in the liver. |
2005 |
Gastroenterology |
pmid:15765409
|
Kaplan BL et al. |
2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2. |
2005 |
J. Leukoc. Biol. |
pmid:15774549
|
Lauckner JE et al. |
The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16365309
|
Chen J et al. |
Finding of endocannabinoids in human eye tissues: implications for glaucoma. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15823551
|
Hill MN et al. |
Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala. |
2005 |
Eur. J. Pharmacol. |
pmid:16324692
|
Gokoh M et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes. |
2005 |
FEBS Lett. |
pmid:16288744
|
Straiker A and Mackie K |
Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. |
2005 |
J. Physiol. (Lond.) |
pmid:16179366
|
Iturralde M et al. |
Characterization of the lipolytic pathways that mediate free fatty acid release during Fas/CD95-induced apoptosis. |
2005 |
Apoptosis |
pmid:16215685
|
Engeli S et al. |
Activation of the peripheral endocannabinoid system in human obesity. |
2005 |
Diabetes |
pmid:16186383
|
Safo PK and Regehr WG |
Endocannabinoids control the induction of cerebellar LTD. |
2005 |
Neuron |
pmid:16301180
|
Alger BE |
Endocannabinoid identification in the brain: studies of breakdown lead to breakthrough, and there may be NO hope. |
2005 |
Sci. STKE |
pmid:16278487
|
Maccarrone M et al. |
Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. |
2005 |
Mol. Hum. Reprod. |
pmid:15563449
|
Rademacher DJ et al. |
Waterborne lead exposure affects brain endocannabinoid content in male but not female fathead minnows (Pimephales promelas). |
2005 |
Neurotoxicology |
pmid:15527869
|
Shoemaker JL et al. |
Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:16081674
|
Sipe JC et al. |
Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. |
2005 |
J. Leukoc. Biol. |
pmid:15845647
|
Jung KM et al. |
Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. |
2005 |
Mol. Pharmacol. |
pmid:16051747
|
Makara JK et al. |
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. |
2005 |
Nat. Neurosci. |
pmid:16116451
|
Ligresti A et al. |
Endocannabinoid metabolic pathways and enzymes. |
2005 |
Curr Drug Targets CNS Neurol Disord |
pmid:16375679
|
Secko D |
Analgesia through endogenous cannabinoids. |
2005 |
CMAJ |
pmid:16103504
|
Maejima T et al. |
Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum. |
2005 |
J. Neurosci. |
pmid:16033892
|
Panikashvili D et al. |
CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition. |
2005 |
J. Cereb. Blood Flow Metab. |
pmid:15729296
|
Gopez JJ et al. |
Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. |
2005 |
Neurosurgery |
pmid:15730585
|
Zhao Q et al. |
2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells. |
2005 |
J. Biol. Chem. |
pmid:15886210
|
Rouzer CA and Marnett LJ |
Glycerylprostaglandin synthesis by resident peritoneal macrophages in response to a zymosan stimulus. |
2005 |
J. Biol. Chem. |
pmid:15917246
|
Nithipatikom K et al. |
A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15919052
|
Darmani NA et al. |
Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew. |
2005 |
Neuropharmacology |
pmid:15921709
|
Kola B et al. |
Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. |
2005 |
J. Biol. Chem. |
pmid:15899896
|
Shoemaker JL et al. |
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15901805
|
Saario SM et al. |
Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. |
2005 |
Chem. Biol. |
pmid:15975510
|
Di S et al. |
Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. |
2005 |
J. Physiol. (Lond.) |
pmid:16239276
|
Gauthier KM et al. |
Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15528233
|
Gabbay E et al. |
Endocannabinoids and liver disease--review. |
2005 |
Liver Int. |
pmid:16162147
|
Vandevoorde S et al. |
Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:16181610
|
Cabranes A et al. |
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. |
2005 |
Neurobiol. Dis. |
pmid:16242629
|
Ramos JA et al. |
Therapeutic potential of the endocannabinoid system in the brain. |
2005 |
Mini Rev Med Chem |
pmid:16026307
|
Wagner JA et al. |
Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts. |
2005 |
J. Cardiovasc. Pharmacol. |
pmid:16116341
|
McPartland JM et al. |
Cannabimimetic effects of osteopathic manipulative treatment. |
2005 |
J Am Osteopath Assoc |
pmid:16118355
|
Wahn H et al. |
The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:16055511
|
Kim J and Alger BE |
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. |
2004 |
Nat. Neurosci. |
pmid:15184902
|
Witting A et al. |
Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice. |
2004 |
J. Neurochem. |
pmid:15189359
|
Stanke-Labesque F et al. |
2-Arachidonoyl glycerol induces contraction of isolated rat aorta: role of cyclooxygenase-derived products. |
2004 |
Cardiovasc. Res. |
pmid:15194472
|
Oka S et al. |
2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. |
2004 |
J. Leukoc. Biol. |
pmid:15316028
|
Nithipatikom K et al. |
2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. |
2004 |
Cancer Res. |
pmid:15604240
|
González S et al. |
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. |
2004 |
Drug Alcohol Depend |
pmid:15099659
|
Valenti M et al. |
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. |
2004 |
Cell. Mol. Life Sci. |
pmid:15095014
|
Kishimoto S et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. |
2004 |
J. Biochem. |
pmid:15115777
|
Hájos N et al. |
Endocannabinoid transport tightly controls 2-arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404. |
2004 |
Eur. J. Neurosci. |
pmid:15182306
|
Vannacci A et al. |
The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15187170
|
Maestroni GJ |
The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein. |
2004 |
FASEB J. |
pmid:15385435
|
Walter L et al. |
ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase. |
2004 |
J. Neurosci. |
pmid:15371507
|
Dinh TP et al. |
RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. |
2004 |
Mol. Pharmacol. |
pmid:15272052
|
Malorni W et al. |
Morphological evidence that 2-arachidonoylglycerol is a true agonist of human platelets. |
2004 |
Thromb. Haemost. |
pmid:15543349
|
Melis M et al. |
Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. |
2004 |
J. Neurosci. |
pmid:15564588
|
Sugiura T et al. |
New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation. |
2004 |
J. Pharmacol. Sci. |
pmid:15599096
|
Saario SM et al. |
Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. |
2004 |
Biochem. Pharmacol. |
pmid:15013854
|
Alberich Jordà M et al. |
The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner. |
2004 |
Blood |
pmid:15039279
|
Witting A et al. |
P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:14976257
|
Carrier EJ et al. |
Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. |
2004 |
Mol. Pharmacol. |
pmid:15044630
|
Golech SA et al. |
Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. |
2004 |
Brain Res. Mol. Brain Res. |
pmid:15548432
|
Mukherjee S et al. |
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors. |
2004 |
Eur. J. Pharmacol. |
pmid:15556131
|
Guo J and Ikeda SR |
Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. |
2004 |
Mol. Pharmacol. |
pmid:14978245
|
Piomelli D |
The endogenous cannabinoid system and the treatment of marijuana dependence. |
2004 |
Neuropharmacology |
pmid:15464150
|
Ghafouri N et al. |
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. |
2004 |
Br. J. Pharmacol. |
pmid:15492019
|
Motobe T et al. |
Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome. |
2004 |
Shock |
pmid:14676677
|